Top Markets
#1 CoW Protocol CoW Protocol +65.62%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +15.44%
#6 Velvet Velvet +15.00%
#7 Humanity Humanity +14.65%
#8 The Black Bull The Black Bull +13.24%
#9 Tutorial Tutorial +12.75%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
CoW Protocol CoW Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Pozycja w akcjach #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Cena akcji
$0.00060315
Ostatnia synchronizacja: 2024-09-27
Kapitalizacja rynkowa
$1.65M
Zmiana (1 dzień)
19.64%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Amniotics AB (publ) (AMNI)

Kategoria

Healthcare
Zyski dla Amniotics AB (publ) (AMNI)
Zyski w Dec 2023 TTM: $-3.09M
Według najnowszych raportów finansowych Amniotics AB (publ), obecny zysk firmy wynosi $-3.09M. W roku 2022 firma osiągnęła zysk w wysokości $-4.61M, wzrost w porównaniu do zysku z roku 2021, który wynosił $-5.92M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Amniotics AB (publ) od 2018 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE